Recommendations for the management of irritable bowel syndrome in family practice

CMAJ. Canadian Medical Association Journal

Volumn 161, Issue 2, 1999, Pages 154-160

  Paterson, William G ^a,e   Thompson, W Grant ^b   Vanner, Stephen J ^a   Faloon, Thomas R ^c   Rosser, Walter W ^d   Birtwhistle, Richard W ^a   Morse, Janet L ^f   Touzel, Thomas A ^f   Armstrong, David ^f   Bailey, Thomas ^f   Boivin, Michel ^f   Bradette, Marc ^f   Briggs, Deborah ^f   Camilleri, Michael ^f   Clément, Louise ^f   Couel, Alain ^f   Davidson, Paul ^f   Depew, William ^f   Diamant, Nicholas ^f   Drossman, Douglas A ^f   Dubé, Catherine ^f   Flynn, Leslie ^f   Gazendam, Mary Kate ^f   Godwin, N Marshall ^f   Heaton, Kenneth W ^f   Klein, Kenneth ^f   Leddin, Desmond ^f   Mader, Judy ^f   Murat, Brian ^f   Myers, Kathryn ^f   Prest, Marcia ^f   Renda Moore, Catherine ^f   Reynolds, Richard ^f   Toner, Brenda ^f   Touzel, Liz ^f   Turnbull, Geoffrey ^f   more..

^a QUEEN S UNIVERSITY   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

^c UNIVERSITY OF OTTAWA   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

^e HOTEL DIEU HOSPITAL   (Canada)

^f NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIARRHEAL AGENT; LOPERAMIDE; SPASMOLYTIC AGENT;

ARTICLE; CANADA; DIET THERAPY; EVIDENCE BASED MEDICINE; GENERAL PRACTITIONER; HEALTH PRACTITIONER; HUMAN; IRRITABLE COLON; MEDICAL SPECIALIST; PATIENT EDUCATION; SOCIAL PSYCHOLOGY;

EID: 0033609492     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: None     Document Type: Article

References (69)

1. 1. Thompson WG. Irritable bowel syndrome: prevalence, prognosis and consequences. CMAJ 1986;134(2):111-3.
2. Drossman DA, Li Z, Andruzzi E, Temple R, Talley NJ, Thompson WG, et al. US householder survey of functional gastrointestinal disorders: prevalence, sociodemography and health impact. Dig Dis Sci 1993;38:1569-80.
3. Heaton KW, O'Donnell LJD, Braddon FEM, Mountford RA, Hughes AO, Cripps PJ. Symptoms of irritable bowel syndrome in a British urban community: consulters and nonconsulters. Gastroenterology 1992;102:1962-7.
4. Thompson WG, Heaton KW, Smythe GT, Smythe C. Irritable bowel syndrome in general practice [abstract]. Gastroenterology 1997;112:A837.
5. Cook DJ, Guyatt GH, Laupacis A, Sackett DL. Rules of evidence and clinical recommendations on the use of antithrombotic agents. Chest 1992;102(Suppl):305S-311S.
6. Manning AP, Thompson WG, Heaton KW, Morris AF. Towards positive diagnosis of the irritable bowel. BMJ 1978;2:653-4.
7. Fielding JF. "Inflammatory" bowel disease. BMJ 1985;290:47-8.
8. Jones R, Lydeard S. Irritable bowel syndrome in the general population. BMJ 1992;304:87-90.
9. McIntosh D, Thompson WG, Patel D, Barr JR, Guindi M. Is rectal biopsy necessary in irritable bowel syndrome? Am J Gastroenterol 1992;87:1407-9.
10. Olibuyide IO, Olawuyi F, Fassanmade AA. A study of irritable bowel syndrome diagnosed by Manning criteria in an African population. Dig Dis Sci 1995;40:983-5.
11. Agreus L, Svardsudd K, Nyren O, Tibblin G. The epidemiology of abdominal symptoms: prevalence and demographic characteristics in a Swedish adult population. A report from the abdominal symptom study. Scand J Gastroenterol 1994;29:102-9.
12. Taub E, Cuevas JL, Cook EW, Crowell M, Whitehead WE. Irritable bowel syndrome defined by factor analysis. Dig Dis Sci 1995;40:2647-55.
13. Talley NJ, Phillips SF, Melton LJ, Mulvihill C, Wiltgen C, Zinsmeister AR. Diagnostic value of the Manning criteria in irritable bowel syndrome. Gut 1990;31:77-81.
14. Thompson WG. Gender differences in irritable bowel symptoms. Eur J Gastroenterol Hepatol 1997;9:299-302.
15. Smith RC, Greenbaum DS, Vancouver JB, Henry RC, Reinhart MA, Greenbaum RB, et al. Gender differences in Manning criteria in the irritable bowel syndrome. Gastroenterology 1991;100:591-5.
16. Whitehead WF, Chaussade S, Corazziari E, Kumar D. Report of an international workshop on management of constipation. Gastroenterol Int 1991;4:99-113.
17. Rao KP, Gupta S, Jain AK, Agrawal AK, Gupta JP. Evaluation of Manning's criteria in the diagnosis of irritable bowel syndrome. J Assoc Physician India 1993;41:357-8.
18. Jeong H, Lee HR, Yoo BC, Park SM. Manning criteria in irritable bowel syndrome: its diagnostic significance. Korean J Intern Med 1993;8:34-9.
19. Vanner S, Glenn D, Paterson WG, Depew W, Mackenzie T, Djurfelt M, et al. Diagnosing irritable bowel syndrome: predictive value of the Rome criteria [abstract]. Gastroenterology 1997;112:A47.
20. Thompson WG, Creed FH, Drossman DA, Heaton K, Mazzacca G. Functional bowel disorders and functional abdominal pain. In: Drossman DA, Richter JE, Talley NJ, Thompson WG, Corazziari E, Whitehead WE, editors. Functional Gastrointestinal Disorders. Boston: Little, Brown & Company; 1994. p. 115-73.
21. Kruis W, Thieme CH, Weinzierl M, Schussler P, Hall J, Paulus W. A diagnostic score for the irritable bowel syndrome. Its value in the exclusion of organic disease. Gastroenterology 1984;87:1-7.
22. Talley NJ, Weaver AL, Zinsmeister AR, Melton LJ. Onset and disappearance of gastrointestinal symptoms and functional gastrointestinal disorders. Am J Epidemiol 1992;136:165-77.
23. Thompson WG. Gut reactions. New York: Plenum; 1989. p. 181-211.
24. Chaudhary NA, Truelove SC. The irritable colon syndrome. Q J Med 1962;31:307-22.
25. Neal KR, Hebden J, Spiller R. Prevalence of gastrointestinal symptoms six months after bacterial gastroenteritis and risk factors for the development of the irritable bowel syndrome: a postal survey of patients. BMJ 1997;314:779-82.
26. Stewart GT. Post-dysenteric colitis. BMJ 1995;1:405-9.
27. Drossman DA. Irritable bowel syndrome: the role of psychosocial factors. Stress Med 1994;10:49-55.
28. Fielding JF. The diagnostic sensitivity of physical signs in the irritable bowel syndrome. Ir Med J 1981;74:143-4.
29. Devesa SS, Silverman DT, Young JL Jr, Pollack ES, Brown CC, Horm JW, et al. Cancer incidence and mortality trends among whites in the United States, 1946-84. J Natl Cancer Inst 1987;79:701-70.
30. Rex DK, Weddle RA, Lehman GA, Pound DC, O'Connor KW, Hawes RH, et al. Flexible sigmoidoscopy plus air contrast barium enema versus colonoscopy for suspected lower gastrointestinal bleeding. Gastroenterology 1990;98:855-61.
31. Suarez FL, Savaiano DA, Levitt MD. A comparison of symptoms after the consumption of milk or lactose-hydrolysed milk by people with self-reported severe lactose intolerance. N Engl J Med 1995;333:1-4.
32. Sachar DB. Crohn's disease: a family affair. Gastroenterology 1996;111:813-5.
33. Thompson WG. The angry gut. New York: Plenum; 1993. p. 269-85.
34. Weston WW, Brown JB, Stewart MA. Patient-centered interviewing. Part I: Understanding patient's experiences. Can Fam Med 1989;35:147-51.
35. Stewart MA. Effective physician-patient communication and health outcomes: a review. CMAJ 1995;152(9):1423-33.
36. Nanda R, James R, Smith H, Dudley CRK, Jewell DP. Food intolerance and the irritable bowel syndrome. Gut 1989;30:1099-104.
37. Wright SH, Snape WJ, Battle W, Cohen S, London RL. Effect of dietary components of gastrocolonic response. Am J Physiol 1980;238:228-32.
38. Stephen AM, Haddad AL, Phillips SF. Passage of carbohydrate into the colon. Gastroenterology 1997;85:589-95.
39. McKee DP, Quigley EMM. Intestinal motility in irritable bowel syndrome: Is IBS a motility disorder? Part I. Definition of IBS and colon motility. Dig Dis Sci 1993;38:1761-72.
40. McKee DP, Quigley EMM. Intestinal motility in irritable bowel syndrome: Is IBS a motility disorder? Part 2. Motility of small bowel, esophagus, stomach and gall-bladder. Dig Dis Sci 1993;38:1773-82.
41. Kellow JE, Phillips SF. Altered and small bowel motility in irritable bowel syndrome is correlated with symptoms. Gastroenterology 1987;92:1885-93.
42. Kellow JE, Langeluddecke PM, Eckersley GM, Jones MP, Tennant CC. Effects of acute psychologic stress on small-intestinal motility in health and the irritable bowel syndrome. Scand J Gastroenterol 1992;27:53-8.
43. Accarino AM, Azpiroz F, Malagalada JR. Selective dysfunction of mechanosensitive intestinal afferents in irritable bowel syndrome. Gastroenterology 1995;108:636-43.
44. Kellow JF, Eckersley GM, Jones MP. Enhanced perception of physiological intestinal motility in the irritable bowel syndrome. Gastroenterology 1991;101:1621-7.
45. Mertz H, Nalihoff B, Munakata J Niazi N, Meyer EA. Altered rectal perception is a biological marker of patients with irritable bowel syndrome. Gastroenterology 1995;109:40-52.
46. Cook IJ, van Eeden A, Collins SM. Patients with irritable bowel syndrome have greater pain tolerance than normal subjects. Gastroenterology 1987;93:727-33.
47. Levitt MD, Furne J, Olsson S. The reaction of passage of gas and colonic bloating to colonic gas production. Ann Intern Med 1996;124:422-4.
48. Colwell LJ, Pratner CM, Phillips SF, Zinsmeisler AR. Effects of an irritable bowel syndrome educational class on health-promoting behavoiurs and symptoms. Am J Gastroenterol 1998;93:901-5.
49. Cann PA, Read NW, Holdsworth CD. What is the benefit of coarse wheat bran in patients with irritable bowel syndrome? Gut 1984;25:168-73.
50. Thompson WG. Doubts about bran [editorial]. Lancet 1994;344:3.
51. Francis CY, Whorwell PJ. Bran and irritable bowel syndrome: time for reappraisal. Lancet 1994;344:39-40.
52. Jones VA, McLaughlan P, Shorthouse M, Workman E, Hunter JO. Food intolerance: a major factor in pathogenesis of the irritable bowel syndrome. Lancet 1982;2:1115-7.
53. Whitehead WE, Crowell MD, Robinson JC, Heller BR, Schuster MM. Effects of stressful life events on vowel symptoms: subjects with irritable bowel symptoms compared with subjects without bowel dysfunction. Gut 1992;33:825-30.
54. Drossman DA, Talley NJ, Olden KW, Leserman J, Barreiro MA. Sexual and physical abuse and gastrointestinal illness: review and recommendations. Ann Intern Med 1995;123:792-4.
55. Drossman DA, Creed FH, Fava GA, Olden KW, Patrick DL, Toner BB, et al. Psychosocial aspects of the functional gastrointestinal disorders. Gastroenterol Int 1995;8:47-90.
56. Sandler RS, Drossman DA, Nathan HP, McKee DC. Symptom complaints and health care seeking behavior in subjects with bowel dysfunction. Gastroenterology 1984;87:314-8.
57. Whitehead WE, Winget C, Fedoravicius AS, Wooley S, Blackwell B. Learned illness behavior in patients with irritable bowel syndrome and peptic ulcer. Dig Dis Sci 1982;27:202-8.
58. Drossman DA, McKee DC, Sandler RS, Mitchell CM, Cramer EM, Lowman BC, et al. Psychosocial factors in the irritable bowel syndrome. A multivariate study of patients and nonpatients with irritable bowel syndrome. Gastroenterology 1988;95:701-8.
59. Drossman DA, Thompson WG. Irritable bowel syndrome: A graduated, multicomponent treatment approach. Ann Intern Med 1992;116:100-16.
60. Blanchard EB, Malamood HS. Psychological treatment of irritable bowel syndrome. Prof Psychol Res Pract 1996;27:241-4.
61. Talley NJ, Owen BK, Boyce P, Paterson K. Psychological treatments for irritable bowel syndrome: a critique of controlled treatment trails. Am J Gastroenterol 1996;91:27-86.
62. Lucey MR, Clark ML, Lowndes J, Dawson AM. Is bran efficacious in irritable bowel syndrome? A double-blind placebo-controlled crossover study. Gut 1987;28:221-5.
63. Thompson WG, Tytgat GNJ, van Blankenstein M, editors. Current topics in gastroenterology and hepatology. New York: Springer-Verlag, 1990, p. 236-45.
64. Cann PA, Read NW, Holdsworth CD, Barends D. Role of loperamide and placebo in management of irritable bowel syndrome. Dig Dis Sci 1984;29:239-47.
65. Awouters F, Megens A, Verlinden M, Schuurkes J, Niemegers C, Janssen PAJ. Loperamide: Survey of studies on mechanism of its activity. Dig Dis Sci 1993;38:977-95.
66. Eherer AJ, Santa Ana CA, Porter J, Fortran JS, Effect of psyllium, calcium polycarbophil, and wheat bran on secretory diarrhoea induced by phenolphthein. Gastroenterology 1993;104:1007-12.
67. Klein KB. Controlled treatment trials in the irritable bowel syndrome: A critique. Gastroenterology 1988;95:232-41.
68. Feinmann C. Pain relief by antidepressants. Pain 1985;23:1-8.
69. Clouse RE. Antidepressants for functional gastrointestinal symptoms. Dig Dis Sci 1994;39:2352-63.